Urology · Clifton, NJ
NPI
1932373578
Since 2008
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
6 Brighton Rd Ste 108
Clifton, NJ, 07012
Phone (973) 337-1328
Groups this clinician bills Medicare through
Medicare paid, 2024
$421K
13,815 services
Medicare patients, 2024
827
Average age 74
Drug cost, 2024
$534K
4,560 prescriptions
Company payments, 2025
$475
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel R Lowe was code 81002 (clinical chemistry), 1,155 times for 693 patients. In total Daniel R Lowe billed 13,815 services in 101 codes, and Medicare paid $421K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81002 Clinical Chemistry | Office | 1,155 | 693 | $3.39 | $3,916 |
| J1836 Injection, metronidazole, 10 mg | Office | 1,153 | 25 | $0.02 | $23.04 |
| 99213 Office E&M - Established | Office | 838 | 560 | $68.70 | $58K |
| 51741 Test - Miscellaneous | Office | 613 | 448 | $10.60 | $6,495 |
| 99214 Office E&M - Established | Office | 590 | 400 | $100.78 | $59K |
| 76857 Ultrasound - Abdomen and Pelvis | Office | 554 | 429 | $39.76 | $22K |
| 36415 Venipuncture Blood Collection | Office | 388 | 322 | $8.52 | $3,306 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 273 | 212 | $91.20 | $25K |
| 76872 Ultrasound - Nonspecific | Office | 263 | 236 | $109.58 | $29K |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 187 | 34 | $0.35 | $66.13 |
| 52000 Cystourethroscopy | Office | 134 | 113 | $210.22 | $28K |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 121 | 112 | $78.89 | $9,546 |
| 84153 Clinical Chemistry | Office | 120 | 118 | $17.62 | $2,114 |
| 84154 Clinical Chemistry | Office | 119 | 117 | $17.76 | $2,114 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 117 | 16 | $138.06 | $16K |
By year: 2022 $440K for 13,347 services; 2023 $448K for 13,114 services; 2024 $421K for 13,815 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 1,155 | 693 | $3.39 | $3,916 |
| 36415 Venipuncture Blood Collection | 388 | 322 | $8.52 | $3,306 |
| 84153 Clinical Chemistry | 120 | 118 | $17.62 | $2,114 |
| 84154 Clinical Chemistry | 119 | 117 | $17.76 | $2,114 |
| 87086 Bacterial Culture | 75 | 54 | $7.84 | $588 |
| 87088 Bacterial Culture | 66 | 46 | $7.85 | $518 |
| 80048 Clinical Chemistry | 45 | 43 | $7.92 | $356 |
| 87186 General Laboratory | 23 | 15 | $8.48 | $195 |
| 87077 Bacterial Culture | 22 | 15 | $7.92 | $174 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel R Lowe prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,428 prescriptions and refills. In total Daniel R Lowe wrote 4,560 Medicare prescriptions that cost $534K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,428 | 3,867 | 452 | $29K |
| Finasteride Generic | 1,214 | 3,472 | 384 | $18K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 303 | 833 | 99 | $7,408 |
| Gemtesa Vibegron | 251 | 434 | 67 | $202K |
| Myrbetriq Mirabegron | 207 | 304 | 52 | $134K |
| Ciprofloxacin Hcl Generic | 189 | 189 | 142 | $1,048 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 164 | 164 | 138 | $557 |
| Solifenacin Succinate Generic | 105 | 232 | 35 | $5,691 |
| Silodosin Generic | 82 | 199 | 26 | $6,427 |
| Dutasteride Generic | 74 | 217 | 27 | $3,118 |
| Cephalexin Generic | 68 | 151 | 28 | $661 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 56 | 138 | 16 | $1,380 |
| Sildenafil Citrate Generic | 43 | 70 | 13 | $451 |
| Potassium Citrate Er Potassium Citrate | 39 | 110 | 11 | $5,867 |
| Tadalafil Generic | 24 | 60 | Under 11 | $1,895 |
Brand drugs: 508 claims; generic drugs: 4,037 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel R Lowe $475 ($475 in general payments such as food, travel and fees) from 10 companies. The largest payer was Procept Biorobotics Corporation with $163.
| Company | Payments | Amount |
|---|---|---|
| Procept Biorobotics Corporation PRCT | 2 | $163 |
| Olympus America Inc. | 4 | $83.39 |
| Edap Technomed Inc | 4 | $80.54 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $31.07 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $30.93 |
| Endo USA, Inc. | 1 | $18.12 |
| Tolmar, Inc. | 1 | $17.69 |
| Blue Earth Diagnostics | 1 | $17.61 |
| Dendreon Pharmaceuticals LLC | 1 | $17.33 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.